Developer docs
API playgroundTry for free, no card

Search company profiles

Pharma Resource Group

Full company profile

uuid000be15

Namestring
Pharma Resource Group
Legal namestring
Pharma Resource Group, Inc.
Websiteurl
pharmarg.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Pharma Resource Group, Inc. (PRG) is a privately held pharmaceutical and life sciences advisory and manufacturing services firm founded in 2007 and headquartered in Royersford, Pennsylvania, with a reported employee base of 11-50 and a referenced bench of 60+ industry veterans. The company delivers four interconnected service lines: (1) Consultancy Services — expert technical consultants and full team deployments across analytical sciences, formulation, regulatory, quality, engineering, manufacturing, microbiology, packaging, and technology transfer; (2) Project-Centric Services — business process outsourcing solutions spanning development through commercialization; (3) an ISO-9001 certified GMP Innovation, Product Development and Commercial Manufacturing Center in Royersford, PA; and (4) Innovation and Applied Technologies — advanced manufacturing platforms including continuous flow API manufacturing, continuous finished dosage formulation, in-line Process Analytical Technology, big-data-enabled scale-up, and novel dosage form technologies.

PRG's go-to-market is sales-led and consultative, serving entrepreneurs, innovators, and startups alongside Fortune 100 pharmaceutical, biotech, nutraceutical, OTC, consumer health, and medical device companies. Revenue is generated through professional services engagements (consultancy/project-based fees) and managed services tied to its manufacturing center, with no minimum order quantities (MOQs) — a deliberate commercial wedge against larger CDMOs. The company monetizes engagement scope via time-and-materials and project-based pricing, with public pricing not disclosed.

PRG operates through wholly-owned subsidiaries in Canada (2013), Brazil (2018), and Europe (2019), and strategic alliances in India (2015) and China (2022), giving it a stated footprint across 15 US states/territories and 14 international countries. In April 2026, PRG was acquired by Pinnaql, Inc., a portfolio company of 3 Boomerang Capital, as Pinnaql's third tuck-in deal in 10 months, combining PRG's scientific development and scale-up expertise with Pinnaql's validation, engineering, quality systems, and regulatory compliance capabilities within a scaled, multi-disciplinary advisory platform.

Short descriptiontext

Pharma Resource Group is a pharmaceutical and life sciences advisory and manufacturing services firm serving entrepreneurs, startups, and Fortune 100 companies across pharma, biotech, nutraceutical, OTC, consumer, and medical device sectors globally. Acquired by Pinnaql in April 2026.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRoyersford, United States
HQ citystring
Royersford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consulting services, life sciences advisory, contract manufacturing organization, GMP product development, technology transfer services
Industry2 codes
PRIMARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Pharmaceutical and Medicine Manufacturing3254
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Pharmaceutical Preparations2834
  • Services-Management Consulting Services8742
Product category
Pharmaceutical and Life Sciences Consulting & Contract Manufacturing Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Consultancy and Technical Consulting Services
TypeProfessional Services
Description

PRG deploys highly skilled technical consultants to augment client project teams or lead entire projects and business processes. Consultants are billed based on engagement scope, typically project-based or time-and-materials arrangements. Services span Analytical Sciences, Change Control Management, Cleaning Development and Validation, Engineering, Manufacturing, Microbiology, Packaging, Procurement and Supply Chain, Project Management, Quality Assurance and Control, Regulatory, Raw Material Science, Research and Development, Statistics, Technical Writing/Document Label Review, and Technology Transfer.

pharmarg.com
2Project-Based Solutions
TypeProfessional Services
Description

PRG provides project-centric engagements including pharmaceutical development projects (oral, liquid, solid, and semi-solid dose prototype development; product and process characterization; GMP manufacturing and packaging for clinical and consumer studies; technology transfer; commercialization), pharmaceutical technical writing (developmental, quality, regulatory), and quality and compliance services (consent decree remediation, deactivation and discontinued product artifact remediation).

pharmarg.com
3Product Development and Manufacturing
TypeProfessional Services
Description

PRG operates its own Innovation, Product Development and GMP Commercial Manufacturing Center offering manufacturing services to innovators, entrepreneurs, and established consumer, OTC, nutraceutical, ethical pharmaceutical, and device companies. Revenue is generated through development fees, manufacturing runs, and scale-up services without imposing minimum order quantities.

pharmarg.com
4Applied Innovation and Technology Platforms
TypeManaged Services
Description

PRG takes on new, breakthrough technology platforms into pilot and commercialization alongside academia and technology partners, demonstrating innovative manufacturing platforms through commercial manufacturing. Revenue derived from technology development, pilot programs, and commercial manufacturing of novel platforms including continuous flow API and novel dosage forms.

pharmarg.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pharma Resource Group provides life sciences advisory, technical consulting, project-based outsourcing, and GMP product development/commercial manufacturing services to pharmaceutical, biotech, nutraceutical, OTC, consumer, and medical device companies. It operates an ISO-9001 certified Innovation, Product Development and Commercial Manufacturing Center in Royersford, Pennsylvania, deploys 60+ industry veteran consultants, and applies proprietary continuous manufacturing and Process Analytical Technology (PAT) platforms — all without imposing minimum order quantities.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Pharma Resource Group (PRG) offers a comprehensive suite of pharmaceutical and life sciences advisory services structured around four interconnected pillars: Consultancy Services (expert technical consultants and full team deployments), Project-Centric Services (BPO solutions spanning development through commercialization), an Innovation/Product Development and GMP Commercial Manufacturing Center (ISO-9001 certified facility), and Innovation and Applied Technologies (advanced manufacturing platforms). The company serves the pharmaceutical, biotech, nutraceutical, OTC, consumer, and medical device sectors from concept through commercialization, with global operations spanning North America, South America, Europe, and Asia-Pacific.

Product and service4 records
1Consultancy Services
CategoryPharmaceutical Consulting Services
Description

Deployment of expert technical consultants and full project teams across Analytical Sciences, Change Control Management, Cleaning Development and Validation, Engineering, Manufacturing, Microbiology, Packaging, Procurement and Supply Chain, Project Management, Quality Assurance and Control, Regulatory, Raw Material Science, R&D, Statistics, Technical Writing, and Technology Transfer — for pharma, biotech, nutraceutical, OTC, consumer, and medical device clients.

2Project-Centric Services
CategoryPharmaceutical Project Outsourcing / BPO
Description

Business Process Outsourcing (BPO) project solutions spanning Analytical, Cleaning Development and Validation, Change Control Management, Technology Transfer, Package Development, Raw Material Assessment and Characterization, Safety in Controlled/GMP environments, Stability, and Technical Writing and Review, plus pharmaceutical development (oral, liquid, solid, semi-solid dose prototype development, product and process characterization, GMP manufacturing and packaging, and commercialization).

3Innovation, Product Development and Commercial Manufacturing Center
CategoryContract Manufacturing and Product Development
Description

ISO-9001 and GMP-certified facility offering collaborative office space, product development suites, commercial manufacturing suites, analytical laboratories, and innovative equipment, backed by a 60+ industry veteran team, for clients who cannot meet typical CMO minimum order quantities.

4Innovation and Applied Technologies
CategoryApplied Pharmaceutical Manufacturing Technology Services
Description

Advanced manufacturing technology platforms including continuous flow API manufacturing, continuous technologies for finished dosage formulation, cleaning technology support and innovation, and novel dosage form technologies (oral, liquid, solid, semi-solid). Uses flexible big-data platforms and in-line Process Analytical Technology (PAT) for model-based scale-up and technology transfer, demonstrated via commercial manufacturing and pilot programs.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Pinnaql
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

Pinnaql, a portfolio company of 3 Boomerang Capital, acquired Pharma Resource Group in April 2026. This was Pinnaql's third tuck-in acquisition in 10 months. The acquisition combines PRG's scientific development expertise with Pinnaql's validation, engineering, quality systems, and regulatory compliance capabilities to support clients from laboratory innovation through manufacturing readiness. PRG's capabilities in scientific development and scale-up complement Pinnaql's existing focus on creating a scaled, multi-disciplinary advisory platform.

pulse2.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

PRG established a strategic alliance with a complementary organization in Jiangsu (north of Shanghai), China in 2022. This partnership enables PRG US to provide high-quality services and solutions to address Asia-Pacific clients' needs.

3Pharma Resource Group Europe SASU (PRG Europe)
Strategic tierCoreTypeOthersAnnounced on2019-07-01
Description

Pharma Resource Group Europe SASU (PRG Europe) was formed in Paris, France in July 2019 to serve European projects. This is a wholly-owned subsidiary of PRG.

pharmarg.com
4Pharma Resource Group Brazil Servicos Farmaceuticos, Ltda. (PRG Brazil)
Strategic tierCoreTypeOthersAnnounced on2018-10-01
Description

Pharma Resource Group Brazil Servicos Farmaceuticos, Ltda. (PRG Brazil) was formed in Sao Paulo, Brazil in October 2018 to address South America projects. This is a wholly-owned subsidiary of PRG.

pharmarg.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

PRG established a strategic alliance with a complementary organization in Hyderabad, India in 2015. This partnership enables PRG US to provide high-quality services and solutions to address Asia-Pacific clients' needs, extending the company's global reach into one of the world's largest pharmaceutical markets.

6Third-Party Development and Clinical Manufacturing Partner
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2014-01-01
Description

In 2014, through a well-established business relationship with a third-party development and clinical manufacturing partner, PRG expanded its offerings to include product, analytical, and technology development services and solutions.

pharmarg.com
7Pharma Resource Group Canada, Inc. (PRG Canada)
Strategic tierCoreTypeOthersAnnounced on2013-09-01
Description

Pharma Resource Group Canada, Inc. (PRG Canada) was formed in British Columbia, Canada in September 2013 with operations in Toronto, Canada, to expand upon North America projects. This is a wholly-owned subsidiary of PRG.

pharmarg.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

PRG works together with academia and technology partners to take on new, breakthrough technology platforms into pilot and commercialization. Based on PRG's own production efforts in support of critical medicines availability as well as client projects, the company demonstrates innovative manufacturing platforms through commercial manufacturing.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Through its Patheon CDMO business, Thermo Fisher provides pharmaceutical development services, clinical and commercial manufacturing, and packaging. Broad incumbent competing across nearly every service PRG offers.

TypeDirect peer
Description

Global pharma consulting and services provider spanning regulatory affairs, development consulting, and quality/compliance. Closely mirrors PRG's consultancy plus development services model for pharma and biotech clients.

TypeBroad incumbent
Description

Large CRO/CDMO providing discovery, safety assessment, CDMO, and consulting services across the pharma and biotech value chain. Broader incumbent offering overlapping development, manufacturing, and advisory services to similar client types.

TypeDirect peer
Description

Global CDMO offering development, manufacturing, and packaging services across oral, injectable, and biologic dosage forms. Most directly comparable large-scale peer to PRG's GMP Commercial Manufacturing Center and product-development services.

TypeBroad incumbent
Description

Global CDMO leader providing API and biopharmaceutical manufacturing, including small-molecule and biologics services. Competes in PRG's API and finished-dose manufacturing space but at vastly greater scale and geographic footprint.

TypeDirect peer
Description

Pharmaceutical consulting and compliance services firm offering regulatory, quality, and clinical services to pharma and biotech. Directly comparable consultancy arm to PRG with overlapping regulatory and quality practice areas.

TypeDirect peer
Description

CDMO providing small-molecule API development and manufacturing, finished dosage forms, and analytical services. Direct competitor in PRG's API and finished-dose manufacturing niche, with deeper scale.

TypeDirect peer
Description

US-based CDMO providing analytical services, formulation development, and GMP manufacturing for small-to-mid pharma and biotech clients. Closest mid-market peer in scale and customer profile to PRG, including innovator/startup engagement models.

TypeEmerging player
Description

CRO/CDMO offering bioanalytical, CMC, formulation development, and GMP manufacturing services to pharma and biotech. Comparable in the integrated analytical-to-manufacturing service mix and small/mid-cap customer focus.

10Velesco Pharmaceutical Services
TypeEmerging player
Description

Small US-based CDMO focused on early-phase formulation development, analytical method development, and clinical-supply manufacturing for virtual and small pharma companies. Closest emerging-player peer to PRG's small-innovator niche.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharma Resource Group

Pharmaceutical and Life Sciences Consulting & Contract Manufacturing Servicespharmarg.com

Pharma Resource Group is a pharmaceutical and life sciences advisory and manufacturing services firm serving entrepreneurs, startups, and Fortune 100 companies across pharma, biotech, nutraceutical, OTC, consumer, and medical device sectors globally. Acquired by Pinnaql in April 2026.

What Pharma Resource Group does

Pharma Resource Group, Inc. (PRG) is a privately held pharmaceutical and life sciences advisory and manufacturing services firm founded in 2007 and headquartered in Royersford, Pennsylvania, with a reported employee base of 11-50 and a referenced bench of 60+ industry veterans. The company delivers four interconnected service lines: (1) Consultancy Services — expert technical consultants and full team deployments across analytical sciences, formulation, regulatory, quality, engineering, manufacturing, microbiology, packaging, and technology transfer; (2) Project-Centric Services — business process outsourcing solutions spanning development through commercialization; (3) an ISO-9001 certified GMP Innovation, Product Development and Commercial Manufacturing Center in Royersford, PA; and (4) Innovation and Applied Technologies — advanced manufacturing platforms including continuous flow API manufacturing, continuous finished dosage formulation, in-line Process Analytical Technology, big-data-enabled scale-up, and novel dosage form technologies.

PRG's go-to-market is sales-led and consultative, serving entrepreneurs, innovators, and startups alongside Fortune 100 pharmaceutical, biotech, nutraceutical, OTC, consumer health, and medical device companies. Revenue is generated through professional services engagements (consultancy/project-based fees) and managed services tied to its manufacturing center, with no minimum order quantities (MOQs) — a deliberate commercial wedge against larger CDMOs. The company monetizes engagement scope via time-and-materials and project-based pricing, with public pricing not disclosed.

PRG operates through wholly-owned subsidiaries in Canada (2013), Brazil (2018), and Europe (2019), and strategic alliances in India (2015) and China (2022), giving it a stated footprint across 15 US states/territories and 14 international countries. In April 2026, PRG was acquired by Pinnaql, Inc., a portfolio company of 3 Boomerang Capital, as Pinnaql's third tuck-in deal in 10 months, combining PRG's scientific development and scale-up expertise with Pinnaql's validation, engineering, quality systems, and regulatory compliance capabilities within a scaled, multi-disciplinary advisory platform.

Pharma Resource Group firmographics

Firmographics
Name
Pharma Resource Group
Legal name
Pharma Resource Group, Inc.
Website
https://pharmarg.com
Company type
Private
Founded year
2007
Operating status
Acquired
Headcount range
51–100 employees
Short description
Pharma Resource Group is a pharmaceutical and life sciences advisory and manufacturing services firm serving entrepreneurs, startups, and Fortune 100 companies across pharma, biotech, nutraceutical, OTC, consumer, and medical device sectors globally. Acquired by Pinnaql in April 2026.
Ownership category
akta.pro rank

Pharma Resource Group industry classification

Industry
Product category
Pharmaceutical and Life Sciences Consulting & Contract Manufacturing Services
NAICS
Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Pharmaceutical consulting services
  • Life sciences advisory
  • Contract manufacturing organization
  • GMP product development
  • Technology transfer services

Where Pharma Resource Group is headquartered

Location

Headquarters

HQ city
Royersford
HQ country
United States
HQ region
North America

Offices6 records

Markets served

Pharma Resource Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Consultancy and Technical Consulting Services: PRG deploys highly skilled technical consultants to augment client project teams or lead entire projects and business processes. Consultants are billed based on engagement scope, typically project-based or time-and-materials arrangements. Services span Analytical Sciences, Change Control Management, Cleaning Development and Validation, Engineering, Manufacturing, Microbiology, Packaging, Procurement and Supply Chain, Project Management, Quality Assurance and Control, Regulatory, Raw Material Science, Research and Development, Statistics, Technical Writing/Document Label Review, and Technology Transfer.
  2. Project-Based Solutions: PRG provides project-centric engagements including pharmaceutical development projects (oral, liquid, solid, and semi-solid dose prototype development; product and process characterization; GMP manufacturing and packaging for clinical and consumer studies; technology transfer; commercialization), pharmaceutical technical writing (developmental, quality, regulatory), and quality and compliance services (consent decree remediation, deactivation and discontinued product artifact remediation).
  3. Product Development and Manufacturing: PRG operates its own Innovation, Product Development and GMP Commercial Manufacturing Center offering manufacturing services to innovators, entrepreneurs, and established consumer, OTC, nutraceutical, ethical pharmaceutical, and device companies. Revenue is generated through development fees, manufacturing runs, and scale-up services without imposing minimum order quantities.
  4. Applied Innovation and Technology Platforms: PRG takes on new, breakthrough technology platforms into pilot and commercialization alongside academia and technology partners, demonstrating innovative manufacturing platforms through commercial manufacturing. Revenue derived from technology development, pilot programs, and commercial manufacturing of novel platforms including continuous flow API and novel dosage forms.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Pharma Resource Group product offering

Product offering

Core offering

Pharma Resource Group provides life sciences advisory, technical consulting, project-based outsourcing, and GMP product development/commercial manufacturing services to pharmaceutical, biotech, nutraceutical, OTC, consumer, and medical device companies. It operates an ISO-9001 certified Innovation, Product Development and Commercial Manufacturing Center in Royersford, Pennsylvania, deploys 60+ industry veteran consultants, and applies proprietary continuous manufacturing and Process Analytical Technology (PAT) platforms — all without imposing minimum order quantities.

Product overview

Pharma Resource Group (PRG) offers a comprehensive suite of pharmaceutical and life sciences advisory services structured around four interconnected pillars: Consultancy Services (expert technical consultants and full team deployments), Project-Centric Services (BPO solutions spanning development through commercialization), an Innovation/Product Development and GMP Commercial Manufacturing Center (ISO-9001 certified facility), and Innovation and Applied Technologies (advanced manufacturing platforms). The company serves the pharmaceutical, biotech, nutraceutical, OTC, consumer, and medical device sectors from concept through commercialization, with global operations spanning North America, South America, Europe, and Asia-Pacific.

Differentiator

Problem solved

Functional benefit

Products and services

  • Consultancy Services Deployment of expert technical consultants and full project teams across Analytical Sciences, Change Control Management, Cleaning Development and Validation, Engineering, Manufacturing, Microbiology, Packaging, Procurement and Supply Chain, Project Management, Quality Assurance and Control, Regulatory, Raw Material Science, R&D, Statistics, Technical Writing, and Technology Transfer — for pharma, biotech, nutraceutical, OTC, consumer, and medical device clients.
  • Project-Centric Services Business Process Outsourcing (BPO) project solutions spanning Analytical, Cleaning Development and Validation, Change Control Management, Technology Transfer, Package Development, Raw Material Assessment and Characterization, Safety in Controlled/GMP environments, Stability, and Technical Writing and Review, plus pharmaceutical development (oral, liquid, solid, semi-solid dose prototype development, product and process characterization, GMP manufacturing and packaging, and commercialization).
  • Innovation, Product Development and Commercial Manufacturing Center ISO-9001 and GMP-certified facility offering collaborative office space, product development suites, commercial manufacturing suites, analytical laboratories, and innovative equipment, backed by a 60+ industry veteran team, for clients who cannot meet typical CMO minimum order quantities.
  • Innovation and Applied Technologies Advanced manufacturing technology platforms including continuous flow API manufacturing, continuous technologies for finished dosage formulation, cleaning technology support and innovation, and novel dosage form technologies (oral, liquid, solid, semi-solid). Uses flexible big-data platforms and in-line Process Analytical Technology (PAT) for model-based scale-up and technology transfer, demonstrated via commercial manufacturing and pilot programs.

Companies that use Pharma Resource Group

Customer profile

Segments4 records

Ideal customer profiles3 records

Pharma Resource Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Pharma Resource Group partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • PinnaqlcoreStrategic or Co-development Partner · 30 April 2026Pinnaql, a portfolio company of 3 Boomerang Capital, acquired Pharma Resource Group in April 2026. This was Pinnaql's third tuck-in acquisition in 10 months. The acquisition combines PRG's scientific development expertise with Pinnaql's validation, engineering, quality systems, and regulatory compliance capabilities to support clients from laboratory innovation through manufacturing readiness. PRG's capabilities in scientific development and scale-up complement Pinnaql's existing focus on creating a scaled, multi-disciplinary advisory platform.
  • Strategic Alliance Partner (Jiangsu, China)minorStrategic or Co-development Partner · 1 January 2022PRG established a strategic alliance with a complementary organization in Jiangsu (north of Shanghai), China in 2022. This partnership enables PRG US to provide high-quality services and solutions to address Asia-Pacific clients' needs.
  • Pharma Resource Group Europe SASU (PRG Europe)coreOthers · 1 July 2019Pharma Resource Group Europe SASU (PRG Europe) was formed in Paris, France in July 2019 to serve European projects. This is a wholly-owned subsidiary of PRG.
  • Pharma Resource Group Brazil Servicos Farmaceuticos, Ltda. (PRG Brazil)coreOthers · 1 October 2018Pharma Resource Group Brazil Servicos Farmaceuticos, Ltda. (PRG Brazil) was formed in Sao Paulo, Brazil in October 2018 to address South America projects. This is a wholly-owned subsidiary of PRG.
  • Strategic Alliance Partner (Hyderabad, India)minorStrategic or Co-development Partner · 1 January 2015PRG established a strategic alliance with a complementary organization in Hyderabad, India in 2015. This partnership enables PRG US to provide high-quality services and solutions to address Asia-Pacific clients' needs, extending the company's global reach into one of the world's largest pharmaceutical markets.
  • Third-Party Development and Clinical Manufacturing PartnerminorStrategic or Co-development Partner · 1 January 2014In 2014, through a well-established business relationship with a third-party development and clinical manufacturing partner, PRG expanded its offerings to include product, analytical, and technology development services and solutions.
  • Pharma Resource Group Canada, Inc. (PRG Canada)coreOthers · 1 September 2013Pharma Resource Group Canada, Inc. (PRG Canada) was formed in British Columbia, Canada in September 2013 with operations in Toronto, Canada, to expand upon North America projects. This is a wholly-owned subsidiary of PRG.
  • Academia and Technology PartnersminorStrategic or Co-development PartnerPRG works together with academia and technology partners to take on new, breakthrough technology platforms into pilot and commercialization. Based on PRG's own production efforts in support of critical medicines availability as well as client projects, the company demonstrates innovative manufacturing platforms through commercial manufacturing.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Pharma Resource Group competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific (Patheon): Through its Patheon CDMO business, Thermo Fisher provides pharmaceutical development services, clinical and commercial manufacturing, and packaging. Broad incumbent competing across nearly every service PRG offers.
  • Charles River Laboratories: Large CRO/CDMO providing discovery, safety assessment, CDMO, and consulting services across the pharma and biotech value chain. Broader incumbent offering overlapping development, manufacturing, and advisory services to similar client types.
  • Lonza: Global CDMO leader providing API and biopharmaceutical manufacturing, including small-molecule and biologics services. Competes in PRG's API and finished-dose manufacturing space but at vastly greater scale and geographic footprint.

Direct peers

  • PharmaLex: Global pharma consulting and services provider spanning regulatory affairs, development consulting, and quality/compliance. Closely mirrors PRG's consultancy plus development services model for pharma and biotech clients.
  • Catalent: Global CDMO offering development, manufacturing, and packaging services across oral, injectable, and biologic dosage forms. Most directly comparable large-scale peer to PRG's GMP Commercial Manufacturing Center and product-development services.
  • ProPharma Group: Pharmaceutical consulting and compliance services firm offering regulatory, quality, and clinical services to pharma and biotech. Directly comparable consultancy arm to PRG with overlapping regulatory and quality practice areas.
  • Cambrex: CDMO providing small-molecule API development and manufacturing, finished dosage forms, and analytical services. Direct competitor in PRG's API and finished-dose manufacturing niche, with deeper scale.
  • Alcami: US-based CDMO providing analytical services, formulation development, and GMP manufacturing for small-to-mid pharma and biotech clients. Closest mid-market peer in scale and customer profile to PRG, including innovator/startup engagement models.

Emerging players

  • Frontage Laboratories: CRO/CDMO offering bioanalytical, CMC, formulation development, and GMP manufacturing services to pharma and biotech. Comparable in the integrated analytical-to-manufacturing service mix and small/mid-cap customer focus.
  • Velesco Pharmaceutical Services: Small US-based CDMO focused on early-phase formulation development, analytical method development, and clinical-supply manufacturing for virtual and small pharma companies. Closest emerging-player peer to PRG's small-innovator niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Pharma Resource Group compliance and trust

Trust signal

Compliance1 record

Pharma Resource Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharma Resource Group leadership team

Management profile

Number of profiles

Profiles9 records

Pharma Resource Group subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Pharma Resource Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharma Resource Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Resource Group

What does Pharma Resource Group do?

Pharma Resource Group provides life sciences advisory, technical consulting, project-based outsourcing, and GMP product development/commercial manufacturing services to pharmaceutical, biotech, nutraceutical, OTC, consumer, and medical device companies. It operates an ISO-9001 certified Innovation, Product Development and Commercial Manufacturing Center in Royersford, Pennsylvania, deploys 60+ industry veteran consultants, and applies proprietary continuous manufacturing and Process Analytical Technology (PAT) platforms — all without imposing minimum order quantities.

Is Pharma Resource Group a public or private company?

Pharma Resource Group is a private company. It is classified as corporate owned and is currently acquired.

When was Pharma Resource Group founded?

Pharma Resource Group was founded in 2007. It employs 51 to 100 people.

Where is Pharma Resource Group based?

Pharma Resource Group is headquartered in Royersford, United States, in the North America region.

How does Pharma Resource Group make money?

Four revenue lines are on record. Consultancy and Technical Consulting Services are the primary driver. The others are project-Based Solutions, product Development and Manufacturing and applied Innovation and Technology Platforms.

Who are Pharma Resource Group's main competitors?

Broad incumbents on record are Thermo Fisher Scientific (Patheon), Charles River Laboratories and Lonza. Direct peers are PharmaLex, Catalent, ProPharma Group, Cambrex and Alcami. Emerging players are Frontage Laboratories and Velesco Pharmaceutical Services.

Does Pharma Resource Group have an API?

No public API is recorded for Pharma Resource Group.

What industry is Pharma Resource Group in?

Pharma Resource Group's product category is Pharmaceutical and Life Sciences Consulting & Contract Manufacturing Services. Its primary akta.pro industry code is HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 325412 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePinnaql Acquires Pharma Resource Group, Expanding Engineering, Validation, Tech Transfer, and Manufacturing Support for Life Sciences ClientsPinnaql acquired Pharma Resource Group, a consulting firm with nearly two decades of experience, to expand its formulation development, technology transfer, and manufacturing support. The acquisition integrates PRG's analytical and manufacturing capabilities, giving clients a single partner for product lifecycle services. It follows Pinnaql's earlier integration of VEG.Pulse 2.0Pinnaql Acquires Pharma Resource Group To Expand Scientific And Manufacturing Advisory CapabilitiesPinnaql, a portfolio company of 3 Boomerang Capital, has acquired Pharma Resource Group, a provider of analytical sciences, formulation, and manufacturing advisory services to pharmaceutical and life sciences companies. The acquisition represents Pinnaql's third tuck-in deal in the past 10 months and combines PRG's scientific development expertise with Pinnaql's validation, engineering, quality systems, and regulatory compliance capabilities to support clients from laboratory innovation through manufacturing readiness.PR NewswirePinnaql Acquires Pharma Resource Group, Further Expanding Scientific and Manufacturing Advisory CapabilitiesPinnaql, Inc., a portfolio company of 3 Boomerang Capital, has acquired Pharma Resource Group, Inc., a provider of analytical sciences, formulation, scientific writing, manufacturing, and change control advisory services to the pharmaceutical and life sciences industries. The transaction marks Pinnaql's third tuck-in acquisition in 10 months, building on its prior purchases of Validation & Engineering Group, Inc. as part of its strategy to create a scaled, multi-disciplinary advisory platform. PRG's capabilities in scientific development and scale-up complement Pinnaql's existing focus on validation, engineering, quality systems, and regulatory compliance.citybizPinnaql Expands Life Sciences Platform with Acquisition of Pharma Resource GroupPinnaql acquired Pharma Resource Group, a provider of scientific, regulatory, and manufacturing advisory services, to broaden its end-to-end support across drug development and commercialization. The deal is Pinnaql's third add-on in 10 months, integrating PRG's scale-up expertise with Pinnaql's validation and compliance capabilities. The combined platform aims to reduce execution risk and accelerate path to manufacturing readiness.